Session Abstract – PMWC 2025 Silicon Valley
Track 2
Track Chair: Sam Perli, ThinkHat
Session: AI-Driven Frontiers in Next-Generation Therapeutics
This session explores groundbreaking advancements in AI-driven small molecule discovery, antibody-drug conjugates (ADCs) and sequence medicines including mRNA vaccines and AAVS based gene therapy. Panelists will tackle pressing challenges including integrating large-scale datasets, ensuring model interpretability, and addressing regulatory complexities in AI-based drug development. They’ll also highlight emerging opportunities, including the use of generative AI for drug discovery, personalized medicine, accelerating clinical trials, and improving predictive models for patient outcomes.
